


A mediastinal tumour grows in the space between both lungs containing the heart, trachea, esophagus, and major vessels. Five-year survival after surgical resection reaches 88.1% with mean overall survival of 71 months. Malignancy risk increases significantly with tumour size. Around 47% of patients present with superior vena cava syndrome at diagnosis.
According to Dr. George Karimundackal, one of the most experienced thoracic surgeons in Mumbai, mediastinal tumours are the cases that arrive latest because they sit in a location that produces symptoms only once they are already large. Most patients have no idea the space between their lungs contains anything worth worrying about until a scan finds something there.
Stage at Symptoms depend on how much fluid has accumulated and how quickly it developed. Small effusions are The mediastinum divides into anterior, middle, and posterior compartments each associated with different tumour types. Location within the mediastinum largely predicts the likely diagnosis before biopsy results arrive.
Symptoms are absent until the tumour reaches significant size. When they appear, location determines what the patient notices first — and often what specialist they go to first.
Read about mediastinal mass surgery to understand how these tumours are managed surgically at Nanavati Max.
TNot always. Tumour type, compartment location, size, and malignant potential all determine whether surgery is the right first step or whether chemotherapy or radiation comes first.
Surgery combined with chemotherapy and radiation produces the best outcomes for malignant tumours. Surgical resection versus no treatment shows a statistically significant survival difference across all subtypes — even incomplete resection outperforms chemotherapy or radiation alone.
For further reading on thoracic oncology outcomes read Esophageal Cancer Surgery Survival Rate
Before his current Director role at Nanavati Max Super Specialty Hospital, Dr. George Karimundackal was Professor of Thoracic Surgery at the Tata Memorial Hospital and performs mediastinal mass surgery including thymectomy, teratoma resection, and complex anterior mediastinal tumour excision. Fifteen years thoracic-only practice.
Patients with a mediastinal tumour diagnosis ask similar questions at every first consult. What the 4 Ts are thymoma, teratoma, thyroid mass, and lymphoma, the four most common anterior mediastinal tumours. Whether all mediastinal tumours need surgery no, seminoma responds so well to chemotherapy and radiation that surgery is often unnecessary. What the 5-year survival is after surgery 88.1% overall across all histological types. And whether a benign cyst still needs removal often yes, because bronchogenic and pericardial cysts carry infection and progressive growth risk even when completely asymptomatic.
A mediastinal tumour grows in the space between both lungs containing the heart, trachea, and major vessels.
Thymoma, teratoma, thyroid mass, and lymphoma — the four most common anterior mediastinal tumours.
Overall 5-year survival after surgical resection of mediastinal masses reaches 88.1% in published NCBI data.
No. Mediastinal seminoma achieves 5-year OS of 100% with chemotherapy and radiation without surgery in most cases.